As of 2:31 PM on the 23rd, Celltrion Healthcare is trading at 173,000 KRW, down 0.12% from the previous day. This marks a 60.04% increase compared to November 25. Celltrion Healthcare is known as the exclusive distributor of Celltrion's biosimilars.

Today, foreigners have a net purchase of 2,000 shares of Celltrion Healthcare, while institutions have a net sale of 3,000 shares, according to provisional data. Over the past five days, individual investors have net sold 695,258 shares, while foreigners and institutions have net bought 854,092 shares and net sold 126,026 shares, respectively.





[Table] Net Trading Volume of Foreigners and Institutions (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing